Skip to main content
Premium Trial:

Request an Annual Quote

GeneLink Posts $2M in Q2 Revenues, Narrows Loss

NEW YORK (GenomeWeb News) – GeneLink today reported that its second-quarter revenues increased to $2.1 million from $125,000 in the same quarter of 2008.

The company said that virtually all of its revenue came from sales of its LifeMap line of skin care and nutrition formulations based on customers' genetic makeup. GeneLink sells these products through its GeneWize Life Sciences business, which was launched last August.

The Orlando, Fla.-based firm recorded $1.9 million in selling, general, and administrative activities during the quarter, more than double the $853,000 it spent on SG&A in the year-ago period.

The firm recorded zero R&D costs for both the current quarter and the year-ago period.

GeneLink trimmed its second-quarter net loss to $821,000 from $1.1 million for the second quarter of 2008.

The company finished the quarter with cash and cash equivalents of $348,000.

“In addition to focusing on sales growth, GeneLink and GeneWize have embarked on a cost reduction and operational efficiency campaign targeted on accelerating our march toward profitability,” GeneLink’s CEO, Monte Taylor, said in a statement.

The firm did not provide further details of its cost-reduction plan.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.